Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,083 public trials 1,367 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors

NCT00453232

Conditions
Carcinoma, Embryonal, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
Locations
  • Addenbrooke's Hospital Cambridge, England, United Kingdom
  • Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
  • Saint Bartholomew's Hospital London, England, United Kingdom
  • Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle upon Tyne, England, United Kingdom
View Trial Details
Completed

Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT00098878

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Sydney Heamatology and Oncology Clinics Hornsby, New South Wales, Australia
  • Lismore Base Hospital Lismore, New South Wales, Australia
  • Institute of Oncology at Prince of Wales Hospital Randwick, New South Wales, Australia
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
View all 88 locations
View Trial Details
Completed

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

NCT00602082

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
Locations
  • Basildon University Hospital Basildon, England, United Kingdom
  • Addenbrooke's Hospital Cambridge, England, United Kingdom
  • Cookridge Hospital Leeds, England, United Kingdom
  • Leicester Royal Infirmary Leicester, England, United Kingdom
View all 17 locations
View Trial Details
Completed

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

NCT00064051

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Indiana Oncology Hematology Consultants Indianapolis, Indiana, United States
  • University of Minnesota Cancer Center Minneapolis, Minnesota, United States
  • Sarah Cannon Cancer Center at Centennial Medical Center Nashville, Tennessee, United States
View Trial Details
Completed

Elecsys HE4 Chinese Reference Value Study

NCT01738269

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • China PLA General Hospital Beijing, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, China
  • Sun Yat-Sen University Cancer Center Guangzhou, China
  • Shandong University Qilu Hospital Jinan, China
View Trial Details
Completed

Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies

NCT00496860

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +66 more
Locations
  • University of Colorado, Anschutz Cancer Pavillion Aurora, Colorado, United States
  • MD Anderson Cancer Center Orlando Orlando, Florida, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • University of Washington, Seattle Cancer Care Center Seattle, Washington, United States
View Trial Details

Related conditions